Article By:
Rod Raynovich
Wednesday, June 22, 2022 5:36 AM EDT
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
3 Stocks to Buy and Hold for the Next Decade: Eli Lilly, HCA Healthcare, and Seagen
Completely agree with $LLY (executive shenanigans aside) 📈
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
You would think news like this would cause $LLY to jump significantly, but in this case nothing. Why?
Stocks For You To Swing-Trade: LLY CMA TTWO
These look like some good picks. Liking $CMA, $LLY, $TTWO